UBE2L3 and non-small cell lung carcinoma: As the result, UBE2L3 inhibition resulted in increased proportion of cells in G1 phase (p<0.05, Figure 2G and Figure 2H) and a slightly increased apoptosis rate (no significance, data not shown) of NSCLC cells while overexpression of UBE2L3 resulted in a decreased proportion of cells in G1 phase (p<0.05, Supplementary Figure 2F and Supplementary Figure 2G) and a slightly decreased apoptosis rate (no significance, data not shown).